James E. Thomas serves as Executive at Coley Pharmaceutical Group, Inc., where they oversee executive responsibilities. Since joining the company, James E. Thomas has executed 17 insider transactions totaling $3.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 18, 2019 involved selling 63,454 shares valued at $155.5K.
James E. Thomas currently holds 63,454 shares of Coley Pharmaceutical Group, Inc. (COLY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James E. Thomas has been a net buyer of COLY stock. They have purchased $3.5M and sold $0 worth of shares.
James E. Thomas's most recent insider trade was on Apr 18, 2019, when they sold 63,454 shares at $2.45 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 21, 2017 | CASM | $0 | Award | 15,000 | $N/A | Discretionary |
| Jan 9, 2017 | CASM | $0 | Award | 12,500 | $N/A | Discretionary |
| Feb 11, 2015 | CASM | $7.7K | Purchase | 5,938 | $1.30 | Discretionary |
| Feb 11, 2015 | CASM | $2.1M | Purchase | 1,591,037 | $1.30 | Discretionary |
| Feb 11, 2015 | CASM | $10.4K | Purchase | 8,025 | $1.30 | Discretionary |
| Jun 25, 2014 | CASM | $0 | Award | 5,076 | $N/A | Discretionary |
| Jun 24, 2013 | CASM | $0 | Award | 6,211 | $N/A | Discretionary |
| Jun 20, 2012 | CASM | $0 | Award | 5,714 | $N/A | Discretionary |
| Jun 9, 2011 | CASM | $0 | Award | 3,953 | $N/A | Discretionary |
| May 11, 2007 | COLY | $519.6K | Purchase | 60,000 | $8.66 | Discretionary |
| May 10, 2007 | COLY | $868.0K | Purchase | 100,000 | $8.68 | Discretionary |
| May 18, 2006 | COLY | $0 | Other | 3,680 | $N/A | Discretionary |
| May 18, 2006 | COLY | $0 | Other | 2,692 | $N/A | Discretionary |
| May 18, 2006 | COLY | $0 | Other | 1,000,000 | $N/A | Discretionary |
| May 10, 2006 | WMGI | $94.9K | Option Exercise | 21,818 | $4.35 | Discretionary |